Please wait a minute...
Clinical and Experimental Obstetrics & Gynecology  2018, Vol. 45 Issue (2): 283-286    DOI: 10.12891/ceog3815.2018
Case Report Previous articles | Next articles
Two cases of placenta accreta with conservative management
H. Kyozuka1, *(), K. Takiguchi1, A. Owada1, Y. Endo1, M. Kojima1, S. Suzuki1, K. Fujimori1
1 Department of the Obstetrics and Gynecology, School of Medicine, Fukushima Medical University, Fukushima, Japan
Download:  PDF
Export:  BibTeX | EndNote (RIS)      
Abstract  
Placenta accreta is an important obstetric complication which can lead to life-threatening postpartum hemorrhage. The mortality rate has been reported to be high in developing countries. The authors report two cases of patients who were successfully treated with conservative management. Case 1: A 36-year-old woman was diagnosed as having placenta accreta following vaginal delivery. The patient was hemodynamically stable and was given conservative management. On the 74th day postpartum, the retained placenta was naturally delivered without significant hemorrhage. Case 2: A 38-year-old woman was referred to the authors’ tertiary clinic for advanced management of an entirely retained placenta. The patient was hemodynamically stable and opted to preserve the uterus. Conservative management was selected as the course of action. On the 95th day postpartum, the retained placenta with necrosis was naturally delivered without complication. Neither case used methotrexate (MTX) or blood product.
Key words:  Placenta accreta      Conservative management      Postpartum hemorrhage      Half-life of serum hCG     
Published:  10 April 2018     
*Corresponding Author(s):  H. KYOZUKA     E-mail:  Kyozuka@fmu.ac.jp

Cite this article: 

H. Kyozuka, K. Takiguchi, A. Owada, Y. Endo, M. Kojima, S. Suzuki, K. Fujimori. Two cases of placenta accreta with conservative management. Clinical and Experimental Obstetrics & Gynecology, 2018, 45(2): 283-286.

URL: 

https://ceog.imrpress.com/EN/10.12891/ceog3815.2018     OR     https://ceog.imrpress.com/EN/Y2018/V45/I2/283

[1] G. Garuti, E. Castellacci, S. Calabrese, S. Calzolari. Hysteroscopic removal of retained products of conception withenhanced vascularity: a study of reliability[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(4): 472-477.
[2] H.M. Kim, J.Y. Lee, W.J. Seong. Multidetector computed tomography to predict heavy bleeding and need for angiographic embolization in patients with postpartum hemorrhage[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(4): 478-482.
[3] K. Tamura, H. Takahashi, S. Uchida, M. Ogoyama, R. Usui, S. Matsubara. Intrauterine balloon failure: unrecognized placenta accreta spectrum disorders[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(3): 405-408.
[4] K. Lee, S. Lee, H. N. Lee, H. Lim, I. J. Kim, I. Y. Park, M. J. Kim. Uterine necrosis following selective embolization for postpartum hemorrhage: report of four cases and review of literature[J]. Clinical and Experimental Obstetrics & Gynecology, 2019, 46(6): 1020-1025.
[5] Z.R. Zheng, X. Xie, Y. Hou, P. Xie, X. Yu, L. Xie. Intraoperative infrarenal aortic balloon occlusion in pregnancies with placenta accreta, increta, and percreta[J]. Clinical and Experimental Obstetrics & Gynecology, 2019, 46(5): 704-708.
[6] Ichiro Miwa, Masahiro Shinagawa, Terumi Miwa, Keiko Ootani, Masakatsu Sase, Yasuhiko Nakamura. Severe postpartum hemorrhage with placental abruption managed by the uterine sandwich: a case report[J]. Clinical and Experimental Obstetrics & Gynecology, 2019, 46(2): 289-290.
[7] X.W. Sun, X.M. Bai, Q. Chen, J.F. Shen, L. Yang, J.Y. Zhang, X.S. Gu, Q. Yuan, J. Jing, Y. Jin. Preset catheter sheaths for uterine arterial embolization in the cesarean section of pernicious preplacental placenta: its application[J]. Clinical and Experimental Obstetrics & Gynecology, 2019, 46(1): 108-112.
[8] D.H. Im, J.M. Byun, H.S. Jung, D.H. Jeong, B.J. Min, Y.N. Kim, E.J. Jung, K.B. Lee, M.S. Sung, K.T. Kim. The utility of Doppler ultrasonography in diagnosis of delayed postpartum hemorrhage: a case report[J]. Clinical and Experimental Obstetrics & Gynecology, 2018, 45(6): 946-948.
[9] A. Tsiola, D. Marioli, I. Papadimitriou, V. Tsapanos, N. A. Georgopoulos. Increased kisspeptin mRNA expression derived from abnormally adhered placenta: compensatory inhibition of abnormal placental invasion?[J]. Clinical and Experimental Obstetrics & Gynecology, 2018, 45(2): 204-208.
[10] S. Matsubara, H. Takahashi. Cesarean scar pregnancy and uterine artery pseudoaneurysm: preceding or coexisting?[J]. Clinical and Experimental Obstetrics & Gynecology, 2018, 45(1): 72-74.
[11] A. Okada, K. Tanaka, K. Kajitani, S. Nishimoto, H. Nakamura, O. Nakamoto. Near-infrared spectroscopy during cesarean section with common iliac artery balloon occlusion for total placenta previa: a case report[J]. Clinical and Experimental Obstetrics & Gynecology, 2018, 45(1): 112-114.
[12] M. Wang, C. Zhu, Z. Wang. A successful pregnant outcome in patient with Sheehan syndrome: a case report[J]. Clinical and Experimental Obstetrics & Gynecology, 2017, 44(6): 944-945.
[13] D.R. Listijono, S.C. Chuah, F. Rahimpanah. Management of placenta accreta in an Australian tertiary referral centre: a ten-year experience[J]. Clinical and Experimental Obstetrics & Gynecology, 2017, 44(3): 374-378.
[14] T.H. Kim, H.H. Lee, J.M. Kim. Efficacy of computed tomography for the diagnosis of postpartum hemorrhage[J]. Clinical and Experimental Obstetrics & Gynecology, 2017, 44(2): 244-246.
[15] H. Takahashi, R. Usui, H. Suzuki, Y. Baba, T. Suzuki, T. Kuwata, A. Ohkuchi, S. Matsubara. Uterine-fundal hypoechoic mass: a possible ultrasound sign for cesarean scar pregnancy[J]. Clinical and Experimental Obstetrics & Gynecology, 2017, 44(1): 88-92.
No Suggested Reading articles found!